Software as a Medical Device for the Treatment of Patients With PTSD

NCT ID: NCT06589505

Last Updated: 2025-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2/PHASE3

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the efficacy and safety of Software as a Medical Device in patients with Post-Traumatic Stress Disorder (PTSD)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Stress Disorder, PTSD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The Software as a Medical Device1

Group Type EXPERIMENTAL

Software as a Medical Device

Intervention Type DEVICE

The subject will undergo treatment using the Software as a Medical Device

The Software as a Medical Device2

Group Type OTHER

Software as a Medical Device

Intervention Type DEVICE

The subject will undergo treatment using the Software as a Medical Device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Software as a Medical Device

The subject will undergo treatment using the Software as a Medical Device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of PTSD according to the DSM-5
* Subjects who are within 1 to 20 years since index trauma

Exclusion Criteria

* Subjects diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, bipolar I disorder, autism spectrum disorder, or intellectual disability based on DSM-5.
* Subjects diagnosed with any mood disorder and anxiety disorder according to DSM-5 that is the primary focus of treatment in the last 6 months prior to screening, as per the clinical judgement of the investigator
* Subjects who have completed two or more full courses of trauma-focused therapy in the past
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

Sponsor Role collaborator

Otsuka Medical Devices Co., Ltd. Japan

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yamanashi Prefectural Kita Hospital

Yamanashi, Hokkaido, Japan

Site Status RECRUITING

Heart Care Clinic Omachi

Akita, , Japan

Site Status RECRUITING

Aburayama Hospital

Fukuoka, , Japan

Site Status RECRUITING

Ai Sakura Clinic

Fukuoka, , Japan

Site Status RECRUITING

Hatakeyama Clinic

Fukuoka, , Japan

Site Status RECRUITING

Hiro Mental Clinic

Fukuoka, , Japan

Site Status RECRUITING

Hirota Clinic

Fukuoka, , Japan

Site Status RECRUITING

Kurume University Hospital

Fukuoka, , Japan

Site Status RECRUITING

Medical corporation Shinseikai Kaku Mental Clinic

Fukuoka, , Japan

Site Status RECRUITING

Mental Clinic Sakurazaka

Fukuoka, , Japan

Site Status RECRUITING

Nishie Kokorono Clinic

Fukuoka, , Japan

Site Status RECRUITING

Uematsu Mental Clinic

Fukuoka, , Japan

Site Status RECRUITING

PTSD Care Matsumoto Mental Clinic

Gunma, , Japan

Site Status RECRUITING

Goryokai Hospital

Hokkaido, , Japan

Site Status RECRUITING

Sakamoto Misako Mental Clinic

Hyōgo, , Japan

Site Status RECRUITING

Takahashi Psychiatric Clinic

Hyōgo, , Japan

Site Status RECRUITING

Tsukuba Psychosomatics Clinic

Ibaraki, , Japan

Site Status RECRUITING

Musashikosugi J Kokorono Clinic

Kanagawa, , Japan

Site Status RECRUITING

Niki Hearty Hospital

Kumamoto, , Japan

Site Status RECRUITING

Arata Clinic

Nagasaki, , Japan

Site Status RECRUITING

Okayama Psychiatric Medical Center

Okayama, , Japan

Site Status RECRUITING

Barclay Imuro Mental Clinic

Okinawa, , Japan

Site Status RECRUITING

Medical Corporation Mikokorokai Shimizu Clinic

Osaka, , Japan

Site Status RECRUITING

Sho Midori Hospital

Saitama, , Japan

Site Status RECRUITING

Ai Mental Clinic

Tochigi, , Japan

Site Status RECRUITING

i Kokoro Clinic Nihonbashi

Tokyo, , Japan

Site Status RECRUITING

Iidabashi Mental Clinic

Tokyo, , Japan

Site Status RECRUITING

Ikebukuro Olive Mental Clinic

Tokyo, , Japan

Site Status RECRUITING

Kitaikebukuro Kokoro No Clinic

Tokyo, , Japan

Site Status RECRUITING

Maynds Tower Mental Clinic

Tokyo, , Japan

Site Status RECRUITING

Monzennakacho Mental Clinic

Tokyo, , Japan

Site Status RECRUITING

Nippon Medical School Hospital

Tokyo, , Japan

Site Status RECRUITING

Sakurazaka Clinic SophyAnce

Tokyo, , Japan

Site Status RECRUITING

Sangenjaya Nakamura Mental Clinic

Tokyo, , Japan

Site Status RECRUITING

Wakamatsucho Kokoro to Hifu Clinic

Tokyo, , Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kentaro Ishinabe

Role: CONTACT

+81-3-6361-7459

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

+81-3-6361-7459

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Kentaro Ishinabe

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

380-102-0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Deep Brain Stimulation for Treatment Refractory PTSD
NCT03416894 ACTIVE_NOT_RECRUITING NA
Theta-Burst Neuromodulation for PTSD
NCT02769312 COMPLETED PHASE1/PHASE2
3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936 COMPLETED PHASE2